However, the cost of research and development of natural health products is often impossibly steep as the products must be rigorously tested and proven before they can be placed on store shelves.
With this challenge ahead of them, the Alberta “phyto-pharmaceutical” biotech company, SinoVeda, turned to Mitacs-Accelerate to assist in the advanced testing of its latest natural calcium supplement which is currently undergoing clinical trials.
The company is developing a novel cancer vaccine based on a specific antigen and needed the research expertise to help them understand, at a molecular level, how that antigen is expressed in different types of cancer. They turned to Dalhousie postdoctoral fellow Olga Hrytsenko for insight. Olga’s 17 years of molecular biology experience is the “perfect fit” for the project says Marianne Stanford, Director of Research, at Immunovaccine.
As a PhD student in Western University's department of Physiology and Pharmacology, Gurjeev’s research focuses on uncovering molecular mechanisms that predispose low birth weight babies to increased risk of developing cardiovascular diseases in adult life.
Because of this research, BC Children’s Hospital can how examine all new cases of pediatric brain tumors throughout the entirety of Western Canada with precision and accuracy – thus reducing the (often excessive) intensity of treatment for children with cancer while still effectively treating the disease. Below is an exclusive interview with Ms.
The research led to the completion of a motorized incubator device that now enables researchers to observe live cells for days at a time as they are stretched under the microscope. His work may help to cure a devastating skin blistering disease called epidermolysis bullosa simplex. Below is an exclusive interview with Mr.
After having come to Canada for a summer English language camp in 2010, Barbara Paes of Universidade de Brasília was always looking for opportunities to return to Canada. So when her friend told her about the Mitacs Globalink program one week before the application deadline, she hurried to apply before it was too late. Now studying at the University of British Columbia’s Brain Research Centre, Barbara has fallen in love with Canada all over again.
So when he found himself examining protein mutations that cause cardiac arrhythmias in a laboratory at the University of British Columbia’s Department of Biochemistry and Molecular Biology, he knew he’d come a long way from where he once was.
By 2020, it is estimated that diabetes will cost the Canadian healthcare system $16.9 billion a year. In response, Calgary-based Orpyx Medical Technologies is developing a product that is garnering the attention of the diabetes technology community. The SurroSense Rx is a pressure sensitive insole that relays plantar pressure information to a wristwatch, notifying the user when damage is being done to their feet so that behavior can be modified to avoid complications.
Aarya— a third-year biotechnology student— was hoping to be able to hone her laboratory skills and knowledge of life sciences research before completing the final year of her degree. Though she had applied to a highly competitive life sciences research term in New York and was accepted to the prestigious Indian Academy of Sciences research program, Aarya chose to accept an internship with the Mitacs Globalink program because of the chance to take part in cancer research at the University of British Columbia under Dr. Christian Naus in the Department of Cell and Physiological Sciences.